Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2024-10-01 Board/Management Inform…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Valberedningens ledamöter inför Episurf Medicals årsstämma 2025
Board/Management Information Classification · 1% confidence The document announces the composition of the Nomination Committee (Valberedning) for the upcoming 2025 Annual General Meeting. It lists the members, the basis for their selection, and the committee's purpose. This type of announcement regarding board-related committees and governance preparation does not fit into specific financial reporting categories like 10-K or ER, and is best classified as a general regulatory announcement (RNS) as it pertains to corporate governance and meeting preparation.
2024-10-01 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is titled 'DELÅRSRAPPORT 1 JANUARI – 30 JUNI 2024' (Interim Report for Jan 1 – June 30, 2024). It contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary on business performance, strategy, and risks. It is a full interim report, not an announcement or a summary, and it provides substantive financial data for the specified period. H1 2024
2024-07-12 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is explicitly titled 'INTERIM REPORT 1 JANUARY – 30 JUNE 2024'. It contains comprehensive financial statements, including income statements, cash flow analysis, balance sheet data, and management commentary regarding the company's performance for the first half of the fiscal year. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2024
2024-07-12 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) in Episurf Medical AB. It explicitly mentions 'Reason for major shareholding notification' and provides detailed tables showing 'Before the transaction' and 'After the transaction' quantities and percentages, including directly and indirectly held voting rights. This structure perfectly matches the definition of a Major Shareholding Notification.
2024-07-03 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for an individual named Sebastian Jahreskog in Episurf Medical AB. It explicitly states the 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures for shares and voting rights, including percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing type code MRQ.
2024-07-02 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding ('Reason for major shareholding notification Buy') by a specific holder ('Fjärde AP-fonden') in the issuer ('Episurf Medical AB'). It provides the 'Before the transaction' and 'After the transaction' share quantities and resulting percentages, culminating in a 'Published' date. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2024-07-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.